(baglimit)
Just read your story with CCC. Not good. A sad case of poor management and too much debt.
I do think OBJ has a vastly different management culture and a business model built on sound research over an extended period of time.
OBJ has just completed 12 months of clinical trial with P&G and have also secured the services of a royalties expert. No details have been released in relation to the product/s that the OBJ technology will be applied to, however one could assume it may be more than one in a particular product range.
Also clinical trials have been completed with Coty.
There is a lot in the pipeline and unlike the CCC management, no grandiose statements have been made in relation to the company's activities.
OBJ is cashed up and has been in a joint venture development phase for some years with its clients and now both parties are ready to reap the rewards.
Cheers
Hoofa
- Forums
- ASX - By Stock
- technical update
(baglimit)Just read your story with CCC. Not good. A sad case of...
-
- There are more pages in this discussion • 178 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add WFL (ASX) to my watchlist
|
|||||
Last
0.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $1.478M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
WFL (ASX) Chart |
Day chart unavailable